Quarterly report pursuant to Section 13 or 15(d)

Sponsored Research and Clinical Trial Agreements (Tables)

v3.10.0.1
Sponsored Research and Clinical Trial Agreements (Tables)
 6 Months Ended
Jun. 30, 2018
Research and Development [Abstract]  
Schedule of Expense Related to Clinical Research Arrangements
The table below provides a summary of Helocyte’s expense related to its clinical research arrangements, for the three and six months ended June 30, 2018 and 2017, by agreement as recorded in the Condensed Consolidated Statements of Operations:
 
 
 
For the Three Months Ended June 30,
 
For the Six Months Ended June 30,
 
($ in thousands)
 
2018
 
2017
 
2018
 
2017
 
COH Triplex clinical research and support
 
$
–
 
$
535
 
$
–
 
$
1,035
 
COH PepVax clinical research and support
 
 
–
 
 
–
 
 
–
 
 
235
 
COH Pentamer clinical research and support
 
 
204
 
 
12
 
 
204
 
 
12
 
Total licenses acquired expense
 
$
204
 
$
547
 
$
204
 
$
1,282
 
Schedule of Expense Related to Sponsered Research Arrangements
The table below provides a summary of Mustang’s expense related to its sponsored research agreements, for the three and six months ended June 30, 2018 and 2017, by license as recorded in the Condensed Consolidated Statements of Operations:
 
 
 
For the Three Months Ended June 30,
 
For the Six Months Ended June 30,
 
($ in thousands)
 
2018
 
2017
 
2018
 
2017
 
COH CAR T
 
$
500
 
$
500
 
$
1,000
 
$
1,000
 
COH - CD123
 
 
114
 
 
575
 
 
264
 
 
595
 
COH - IL13Ra2
 
 
143
 
 
1,001
 
 
503
 
 
1,010
 
City of Hope – Manufacturing
 
 
115
 
 
–
 
 
229
 
 
–
 
Fred Hutch - CD20
 
 
418
 
 
–
 
 
684
 
 
–
 
Total
 
$
1,290
 
$
2,076
 
$
2,680
 
$
2,605